Home

Envista Holdings Corporation Common Stock (NVST)

20.57
+0.44 (2.19%)

Envista Holdings Corp is a global company focused on providing innovative dental products and technologies aimed at improving oral health care

Through its diverse portfolio, Envista develops and manufactures a wide range of orthodontic appliances, restorative solutions, and digital imaging systems, catering to dental professionals and laboratories. With a commitment to enhancing patient care and advancing dental practices, the company leverages its expertise in science and engineering to drive innovation in the dental industry. Envista strives to empower dental professionals with the tools they need to deliver better outcomes for patients worldwide.

SummaryNewsPress ReleasesChartHistoricalFAQ
Envista’s (NYSE:NVST) Q4 Sales Beat Estimates
Dental products company Envista Holdings (NYSENVST) announced better-than-expected revenue in Q4 CY2024, with sales up 1.1% year on year to $652.9 million. Its non-GAAP profit of $0.24 per share was 9.9% above analysts’ consensus estimates.
Via StockStory · February 5, 2025
Envista Holdings Earnings Review: Q4 Summarybenzinga.com
Via Benzinga · February 5, 2025
Insights into Envista Holdings Q4 Earningsbenzinga.com
Via Benzinga · February 5, 2025
Earnings Scheduled For February 5, 2025benzinga.com
Via Benzinga · February 5, 2025
5 Analysts Have This To Say About Envista Holdingsbenzinga.com
Via Benzinga · January 23, 2025
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?benzinga.com
Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a strong bid unlikely to face competition.
Via Benzinga · December 12, 2024
Demystifying Envista Holdings: Insights From 7 Analyst Reviewsbenzinga.com
Via Benzinga · December 4, 2024
Cracking The Code: Understanding Analyst Reviews For Envista Holdingsbenzinga.com
Via Benzinga · October 23, 2024
7 Analysts Assess Envista Holdings: What You Need To Knowbenzinga.com
Via Benzinga · September 23, 2024
Evaluating Envista Holdings: Insights From 7 Financial Analystsbenzinga.com
Via Benzinga · August 8, 2024
This Wingstop Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursdaybenzinga.com
Via Benzinga · October 31, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 31, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 30, 2024
NVST Stock Earnings: Envista Holdings Misses EPS, Misses Revenue for Q2 2024investorplace.com
NVST stock results show that Envista Holdings missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024
Expert Outlook: Envista Holdings Through The Eyes Of 5 Analystsbenzinga.com
Via Benzinga · July 16, 2024
Forecasting The Future: 5 Analyst Projections For Envista Holdingsbenzinga.com
Via Benzinga · June 25, 2024
Expert Outlook: Envista Holdings Through The Eyes Of 4 Analystsbenzinga.com
Via Benzinga · June 3, 2024
Unveiling 4 Analyst Insights On Envista Holdingsbenzinga.com
Via Benzinga · May 2, 2024
NVST Stock Earnings: Envista Holdings Misses EPS, Misses Revenue for Q1 2024investorplace.com
NVST stock results show that Envista Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · May 1, 2024
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionwhy-com
Shares of Compass Minerals International, Inc. (NYSECMP) fell sharply during Thursday’s session following downbeat results.
Via Benzinga · February 8, 2024
Recap: Envista Holdings Q4 Earningsbenzinga.com
Via Benzinga · February 7, 2024
Earnings Scheduled For February 7, 2024benzinga.com
Companies Reporting Before The Bell • Madison Square Garden (NYSEMSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via Benzinga · February 7, 2024
Analyst Downgrades Dental Player Envista As Outlook Hinges on Improved Commercial Execution, Strategic Initiative Effectivenessbenzinga.com
Envista Holdings Q3 2024 sales beat estimates at $645.6 million. William Blair downgrades to Market Perform with concerns on execution.
Via Benzinga · February 8, 2024
Earnings Outlook For Envista Holdingsbenzinga.com
Via Benzinga · February 6, 2024